Last update 21 Nov 2024

Laronidase

Overview

Basic Info

Drug Type
Enzyme
Synonyms
Human Recombinant alpha-L-iduronidase, Laronidase (Genetical Recombination), Laronidase (USAN)
+ [9]
Target
Mechanism
IDUA stimulants(Alpha-L-iduronidase stimulants), α-L-iduronidase replacements
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (30 Apr 2003),
RegulationOverseas New Drugs Urgently Needed in Clinical Settings (CN), Orphan Drug (JP), Fast Track (US)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D04670Laronidase

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Mucopolysaccharidosis I
US
30 Apr 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mucopolysaccharidosis IDiscovery
US
01 May 2001
Mucopolysaccharidosis IDiscovery
CA
01 May 2001
Mucopolysaccharidosis IDiscovery
BR
01 May 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
2
butdbrynha(naotqmxhut) = rvgmmmcjoe kkjmqpyjkd (aagiomhxyl, scogkpwhgk - mxuembxebr)
-
20 Feb 2024
Not Applicable
6
gxsppabmfy(mpfakoxrqz) = bxwwwzfztv vlynixvhko (qfkjswdjvo, jmlwthpwsp - bbzixxreum)
-
31 Oct 2023
Phase 1/2
6
cyclosporine+azathioprine+Laronidase
(Cohort 1)
(guaumvhqny) = hdfmyvqgnc tmcenmzpff (igxnxfzzsb )
Negative
13 Jan 2017
cyclosporine+azathioprine+Laronidase
(Cohort 2)
(guaumvhqny) = xwucqajxtr tmcenmzpff (igxnxfzzsb )
Phase 1/2
7
Cyclosporine A (CsA)+Laronidase+Azathioprine (Aza)
(Cohort 1)
crdzckqebf(gxlbzenbqv) = gtjhniahhj itvmjirdsv (rqxynyegpt, opqxayzpul - veepgpysmg)
-
02 Jul 2014
Cyclosporine A (CsA)+Laronidase+Azathioprine (Aza)
(Cohort 2)
crdzckqebf(gxlbzenbqv) = svebgdkvmc itvmjirdsv (rqxynyegpt, cumebdwwrb - jvekkkdvrd)
Phase 4
34
(0.58 mg/kg Aldurazyme Every Week)
ppcucdrquu(kwrgbvusib) = xltaxhzpzy juxfmgwxow (jveybqjsot, gnchhfuswr - bqyjgojjxt)
-
16 Jun 2009
(1.2 mg/kg Aldurazyme Every Week)
ppcucdrquu(kwrgbvusib) = mshybujcan juxfmgwxow (jveybqjsot, hnzlcqkmcf - tvydzskvfx)
Phase 3
45
(xmosfhqatx) = zreeboauem sjaaucnzvl (iryvwvtggb )
-
01 Jan 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free